is retatrutide available Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide 20mg | Triple GIP/GLP-1/Glucagon

The mechanisms of most currently used obesity treatments predominantly focus on appetite suppression

However, as of mid-2025, retatrutide has not received regulatory approval in the UK or elsewhere

It has been presented for research buyers who need clear product information, transparent supporting documentation and reliable UK delivery from a professional peptide research supplier

The receptor profiles are different (dual versus triple agonist), the potency per milligram is different, and the side effect profiles are different

PLoS One 13 , e0196625 (2018)

However, medications like compounded GLP-1 therapy can be an effective part of your weight loss program when working with a board-certified physician to achieve your overall health and aesthetic goals